Express Scripts, Others Face ERISA Suit Over EpiPen Costs
Law360, New York (August 29, 2017, 4:09 PM EDT) -- Pharmacy benefit managers Express Scripts Inc., OptumRx Inc. and Prime Therapeutics LLC have agreed to give Mylan Pharmaceuticals Inc.’s EpiPen favorable placement on drug formularies in exchange for kickbacks, employees under Employee Retirement Income Security Act benefit plans claimed in a proposed class action filed Tuesday in Kansas federal court.
Drugmakers such as Mylan inflate the price of EpiPens and other products to be able to rebate a portion of their profit back to pharmacy benefit managers in exchange for preferential formulary placement, the proposed class of consumers who bought EpiPens while enrolled in an employer-provided welfare benefit health plan governed...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!